Source link : https://newshealth.biz/health-news/glp-1-users-may-face-optic-nerve-damage-risk-in-first-year/
TOPLINE: The use of GLP-1 receptor agonists, and particularly liraglutide, was associated with an increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) during the first year of treatment, with the risk being most pronounced in individuals without type 2 diabetes (T2D) or obesity. METHODOLOGY: Researchers conducted a case-control study to examine the association […]
The post GLP-1 Users May Face Optic Nerve Damage Risk in First Year first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-30 07:45:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8